No association of estrogen receptor α and cytochrome P450c17α polymorphisms with age at menopause in a Dutch cohort

被引:23
作者
Kok, HS
Onland-Moret, NC
van Asselt, KM
van Gils, CH
van der Schouw, YT
Grobbee, DE
Peeters, PHM
机构
[1] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 BA Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 BA Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Reprod Med, NL-3508 BA Utrecht, Netherlands
关键词
age at menopause; association study; cytochrome P450c17 alpha; estrogen receptor a; polymorphism;
D O I
10.1093/humrep/deh600
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Age at menopause is under strong genetic control. So far, genetic variations of only one gene, the PvuII polymorphism of the estrogen receptor alpha (ERalpha) gene, have been shown to be associated with age at onset of menopause. This study aims to investigate whether PvuII, XbaI and B-variant polymorphisms of the ERalpha gene, and the MspAI polymorphism of the cytochrome P450c17alpha (CYP17) gene are associated with age at menopause in a Dutch cohort. Methods: DNA was isolated from urine samples of 385 Caucasian women with natural menopause and the genotypes of the four polymorphisms were determined. A questionnaire was used for background characteristics. The genotypes of PvuII, XbaI, MspAI were obtained by PCR restriction fragment length polymorphism analysis. The B-variant was determined with an allele-specific oligonucleotide hybridization method. Two-sided t-tests were performed to assess the association between the four polymorphisms and menopausal age. The PvuII and XbaI polymorphisms were analysed separately as well as in a combined score. Results: The results show that none of the polymorphisms independently, nor the combined genotypes for PvuII and XbaI, were associated with age at natural menopause. Conclusion: No evidence was found for a relationship between common variants of the ERalpha gene and the CYP17 gene with age at natural menopause.
引用
收藏
页码:536 / 542
页数:7
相关论文
共 76 条
[1]   MUTATION IN THE FOLLICLE-STIMULATING-HORMONE RECEPTOR GENE CAUSES HEREDITARY HYPERGONADOTROPIC OVARIAN FAILURE [J].
AITTOMAKI, K ;
LUCENA, JLD ;
PAKARINEN, P ;
SISTONEN, P ;
TAPANAINEN, J ;
GROMOLL, J ;
KASKIKARI, R ;
SANKILA, EM ;
LEHVASLAIHO, H ;
ENGEL, AR ;
NIESCHLAG, E ;
HUHTANIEMI, I ;
DELACHAPELLE, A .
CELL, 1995, 82 (06) :959-968
[2]   CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors [J].
Ambrosone, CB ;
Moysich, KB ;
Furberg, H ;
Freudenheim, JL ;
Bowman, ED ;
Ahmed, S ;
Graham, S ;
Vena, JE ;
Shields, PG .
BREAST CANCER RESEARCH, 2003, 5 (02) :R45-R51
[3]  
ANDERSEN TI, 1994, HUM GENET, V94, P665
[4]   Polymorphisms in CYP1A1 and smoking:: no association with breast cancer risk [J].
Basham, VM ;
Pharoah, PDP ;
Healey, CS ;
Luben, RN ;
Day, NE ;
Easton, DF ;
Ponder, BAJ ;
Dunning, AM .
CARCINOGENESIS, 2001, 22 (11) :1797-1800
[5]  
Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
[6]   Estrogen receptor α gene haplotype is associated with radiographic osteoarthritis of the knee in elderly men and women [J].
Bergink, AP ;
van Meurs, JB ;
Loughlin, J ;
Arp, PP ;
Fang, Y ;
Hofman, A ;
van Leeuwen, JPTM ;
van Duijn, CM ;
Uitterlinden, AG ;
Pols, HAP .
ARTHRITIS AND RHEUMATISM, 2003, 48 (07) :1913-1922
[7]  
Bergman-Jungestrom M, 1999, INT J CANCER, V84, P350, DOI 10.1002/(SICI)1097-0215(19990820)84:4<350::AID-IJC3>3.0.CO
[8]  
2-L
[9]   Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women [J].
Bergman-Jungeström, M ;
Wingren, S .
BRITISH JOURNAL OF CANCER, 2001, 85 (06) :859-862
[10]   AN ESTROGEN-RECEPTOR GENETIC-POLYMORPHISM AND THE RISK OF PRIMARY AND SECONDARY RECURRENT SPONTANEOUS-ABORTION [J].
BERKOWITZ, GS ;
STONE, JL ;
LEHRER, SP ;
MARCUS, M ;
LAPINSKI, RH ;
SCHACHTER, BS .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 171 (06) :1579-1584